You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Mallinckrodt
Express Scripts
AstraZeneca
McKesson

Last Updated: April 2, 2020

DrugPatentWatch Database Preview

IMODIUM A-D EZ CHEWS Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Imodium A-d Ez Chews patents expire, and what generic alternatives are available?

Imodium A-d Ez Chews is a drug marketed by J And J Consumer Inc and is included in one NDA. There is one patent protecting this drug.

The generic ingredient in IMODIUM A-D EZ CHEWS is loperamide hydrochloride. There are eleven drug master file entries for this compound. One hundred and seven suppliers are listed for this compound. Additional details are available on the loperamide hydrochloride profile page.

US ANDA Litigation and Generic Entry Outlook for Imodium A-d Ez Chews

A generic version of IMODIUM A-D EZ CHEWS was approved as loperamide hydrochloride by MYLAN on September 18th, 1991.

  Start Trial

Summary for IMODIUM A-D EZ CHEWS
Drug patent expirations by year for IMODIUM A-D EZ CHEWS
Recent Clinical Trials for IMODIUM A-D EZ CHEWS

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
McNeil ABPhase 1
AllerganPhase 2
University of North Carolina, Chapel HillPhase 2

See all IMODIUM A-D EZ CHEWS clinical trials

Synonyms for IMODIUM A-D EZ CHEWS
1-Piperidinebutanamide, 4-(4-chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenyl-, hydrochloride
1-Piperidinebutanamide, 4-(4-chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenyl-, monohydrochloride
1-Piperidinebutanamide, 4-(4-chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenyl-,hydrochloride
34552-83-5
4-(4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl)-N,N-dimethyl-2,2-diphenylbutanamide hydrochloride
4-(4-(p-Chlorophenyl)-4-hydroxy-1-piperidyl)-N,N-dimethyl-2,2-diphenylbutyramide HCl
4-(4-chlorophenyl)-1-[4-(dimethylamino)-4-oxo-3,3-diphenylbutyl]-4-hydroxypiperidin-1-ium chloride
4-(4-Chlorophenyl)-4-hydroxy-N,.alpha.-diphenyl-1-piperidinebutanamide monohydrochloride
4-(4-Chlorophenyl)-4-hydroxy-N,N-dimethyl-?,?-diphenyl-1-piperidinebutanamide hydrochloride
4-(4-chlorophenyl)-4-hydroxy-N,N-dimethyl-a,a-diphenylpiperidine-1-butyramide monohydrochloride
4-(4-Chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenyl-1-piperidinebutanamidehydrochloride
4-(4-Chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenylpiperidine-1-butyramide monohydrochloride
4-(p-Chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenyl-1-piperidine butyramide HCl
4-(p-Chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenyl-1-piperidinebutyramide hydrochloride
4-(p-Chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenyl-1-piperidinebutyramide monohydrochloride
4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-N,N-dimethyl-2,2-diphenylbutanamide hydrochloride
4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide hydrochloride
4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-n,n-dimethyl-2,2-diphenylbutanamide;hydrochloride
4-[4-(4-chlorophenyl)-4-oxidanyl-piperidin-1-yl]-N,N-dimethyl-2,2-diphenyl-butanamide hydrochloride
552L835
77TI35393C
A822272
AB0013105
AB2000588
AC-8242
ADL 2-1294
AK550233
AKOS015846351
Anti-diarrheal
ARONIS27197
AS-13181
B1392
BCP28441
BLOX
BREK
C29H33ClN2O2.HCl
C29H34Cl2N2O2
CCG-39494
CHEBI:6533
CHEMBL1707
CPD000058466
CS-2522
D00729
Diamode
Diar-Aid
Dissenten
DTXSID00880006
EBD2202345
EINECS 252-082-4
EU-0100708
Fortasec
FT-0627973
H536
HMS1568M10
HMS1922J18
HY-B0418A
Imodium
Imodium (TN)
Imodium A-D
Imosec
Imotil
K-7865
K-Pek II
Kao-Paverin
Kaopectate 1-D
KS-00000GHZ
KS-000048OI
L 4762
L0154
Lopemid
Lopemin
Loperamide Hydrochloride ,(S)
Loperamide (hydrochloride)
Loperamide HCl
Loperamide hydrochloride
Loperamide hydrochloride (JAN/USP)
Loperamide hydrochloride [USAN:JAN]
Loperamide hydrochloride [USAN:USP:JAN]
Loperamide Hydrochloride Capsules
Loperamide hydrochloride for system suitability, European Pharmacopoeia (EP) Reference Standard
Loperamide hydrochloride, British Pharmacopoeia (BP) Reference Standard
Loperamide hydrochloride, European Pharmacopoeia (EP) Reference Standard
Loperamide hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Loperamide hydrochloride, United States Pharmacopeia (USP) Reference Standard
Loperamide hydrochloride, VETRANAL(TM), analytical standard
Loperamide-hydrochloride
Loperamide, HCl
Loperyl
Loseramin
LP00708
LS-114353
Maalox Anti-Diarrheal
Maalox Antidiarrheal
MCULE-8938403173
MFCD00058581
MLS000069779
MLS001148627
MLS002222200
NC00572
NCGC00094059-01
NCGC00094059-02
NCGC00094059-03
NCGC00094059-04
NCGC00094059-05
NCGC00180886-01
NCGC00180886-02
NCGC00261393-01
NSC-696356
NSC-759568
NSC696356
NSC759568
Opera_ID_1508
Pepto Diarrhea Control
PGYPOBZJRVSMDS-UHFFFAOYSA-N
Pharmakon1600-02300241
PJ185
Prestwick_302
Q27107231
R 18,553
R 18553
REGID_for_CID_71420
s2480
SAM002564218
SCHEMBL15048
SMR000058466
SPECTRUM2300241
SR-01000075507
SR-01000075507-1
SR-01000075507-3
SR-01000075507-8
Suprasec
SW196602-3
Tebloc
Tox21_500708
UNII-77TI35393C
Up and up anti diarrheal
W-106729

US Patents and Regulatory Information for IMODIUM A-D EZ CHEWS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J Consumer Inc IMODIUM A-D EZ CHEWS loperamide hydrochloride TABLET, CHEWABLE;ORAL 020448-001 Jul 24, 1997 DISCN Yes No   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Mallinckrodt
Express Scripts
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.